UK Pharmaceuticals Export Market Report by Product Type (Branded Pharmaceuticals, Generic Pharmaceuticals, OTC (Over-The-Counter) Drugs, Biopharmaceuticals, Active Pharmaceutical Ingredients (APIS), Vaccines), Therapeutic Application (Cardiovascular, Oncology, Central Nervous System (CNS), Infectious Diseases, Respiratory, Endocrinology, Dermatology, Gastroenterology, and Others), Distribution Channel (Direct Exports, Contract Manufacturing, Online Pharmacies, and Others), and Region  2024-2032

UK Pharmaceuticals Export Market Report by Product Type (Branded Pharmaceuticals, Generic Pharmaceuticals, OTC (Over-The-Counter) Drugs, Biopharmaceuticals, Active Pharmaceutical Ingredients (APIS), Vaccines), Therapeutic Application (Cardiovascular, Oncology, Central Nervous System (CNS), Infectious Diseases, Respiratory, Endocrinology, Dermatology, Gastroenterology, and Others), Distribution Channel (Direct Exports, Contract Manufacturing, Online Pharmacies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A24927

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
    2.4    Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   UK Pharmaceuticals Export Market – Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   UK Pharmaceuticals Export Market Landscape
    5.1    Historical and Current Market Trends (​2018-2023​)
    5.2    Market Forecast (​2024-2032​)
6   UK Pharmaceuticals Export Market - Breakup by Product Type
    6.1    Branded Pharmaceuticals
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (​2018-2023​)
        6.1.3 Market Forecast (​2024-2032​)
        6.1.4 Market Breakup by Therapeutic Application
        6.1.5 Market Breakup by Distribution Channel
    6.2    Generic Pharmaceuticals
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (​2018-2023​)
        6.2.3 Market Forecast (​2024-2032​)
        6.2.4 Market Breakup by Therapeutic Application
        6.2.5 Market Breakup by Distribution Channel
    6.3    OTC (Over-the-Counter) Drugs
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (​2018-2023​)
        6.3.3 Market Forecast (​2024-2032​)
        6.3.4 Market Breakup by Therapeutic Application
        6.3.5 Market Breakup by Distribution Channel
    6.4    Biopharmaceuticals
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (​2018-2023​)
        6.4.3 Market Forecast (​2024-2032​)
        6.4.4 Market Breakup by Therapeutic Application
        6.4.5 Market Breakup by Distribution Channel
    6.5    Active Pharmaceutical Ingredients (APIs)
        6.5.1 Overview
        6.5.2 Historical and Current Market Trends (​2018-2023​)
        6.5.3 Market Forecast (​2024-2032​)
        6.5.4 Market Breakup by Therapeutic Application
        6.5.5 Market Breakup by Distribution Channel
    6.6    Vaccines
        6.6.1 Overview
        6.6.2 Historical and Current Market Trends (​2018-2023​)
        6.6.3 Market Forecast (​2024-2032​)
        6.6.4 Market Breakup by Therapeutic Application
        6.6.5 Market Breakup by Distribution Channel
    6.7    Attractive Investment Proposition by Product Type
7   UK Pharmaceuticals Export Market - Breakup by Therapeutic Application
    7.1    Cardiovascular
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (​2018-2023​)
        7.1.3 Market Forecast (​2024-2032​)
        7.1.4 Market Breakup by Product Type
        7.1.5 Market Breakup by Distribution Channel
    7.2    Oncology
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (​2018-2023​)
        7.2.3 Market Forecast (​2024-2032​)
        7.2.4 Market Breakup by Product Type
        7.2.5 Market Breakup by Distribution Channel
    7.3    Central Nervous System (CNS)
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (​2018-2023​)
        7.3.3 Market Forecast (​2024-2032​)
        7.3.4 Market Breakup by Product Type
        7.3.5 Market Breakup by Distribution Channel
    7.4    Infectious Diseases
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (​2018-2023​)
        7.4.3 Market Forecast (​2024-2032​)
        7.4.4 Market Breakup by Product Type
        7.4.5 Market Breakup by Distribution Channel
    7.5    Respiratory
        7.5.1 Overview
        7.5.2 Historical and Current Market Trends (​2018-2023​)
        7.5.3 Market Forecast (​2024-2032​)
        7.5.4 Market Breakup by Product Type
        7.5.5 Market Breakup by Distribution Channel
    7.6    Endocrinology
        7.6.1 Overview
        7.6.2 Historical and Current Market Trends (​2018-2023​)
        7.6.3 Market Forecast (​2024-2032​)
        7.6.4 Market Breakup by Product Type
        7.6.5 Market Breakup by Distribution Channel
    7.7    Dermatology
        7.7.1 Overview
        7.7.2 Historical and Current Market Trends (​2018-2023​)
        7.7.3 Market Forecast (​2024-2032​)
        7.7.4 Market Breakup by Product Type
        7.7.5 Market Breakup by Distribution Channel
    7.8    Gastroenterology
        7.8.1 Overview
        7.8.2 Historical and Current Market Trends (​2018-2023​)
        7.8.3 Market Forecast (​2024-2032​)
        7.8.4 Market Breakup by Product Type
        7.8.5 Market Breakup by Distribution Channel
    7.9    Others
        7.9.1 Overview
        7.9.2 Historical and Current Market Trends (​2018-2023​)
        7.9.3 Market Forecast (​2024-2032​)
    7.10    Attractive Investment Proposition by Therapeutic Application
8   UK Pharmaceuticals Export Market - Breakup by Distribution Channel
    8.1    Direct Exports
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (​2018-2023​)
        8.1.3 Market Forecast (​2024-2032​)
        8.1.4 Market Breakup by Product Type
        8.1.5 Market Breakup by Therapeutic Application
    8.2    Contract Manufacturing
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (​2018-2023​)
        8.2.3 Market Forecast (​2024-2032​)
        8.2.4 Market Breakup by Product Type
        8.2.5 Market Breakup by Therapeutic Application
    8.3    Online Pharmacies
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (​2018-2023​)
        8.3.3 Market Forecast (​2024-2032​)
        8.3.4 Market Breakup by Product Type
        8.3.5 Market Breakup by Therapeutic Application
    8.4    Others
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (​2018-2023​)
        8.4.3 Market Forecast (​2024-2032​)
    8.5    Attractive Investment Proposition by Distribution Channel
9   UK Pharmaceuticals Export Market - Breakup by Region
    9.1    London
        9.1.1 Market Drivers
        9.1.2 Historical and Current Market Trends (​2018-2023​)
        9.1.3 Market Breakup by Product Type
        9.1.4 Market Breakup by Therapeutic Application
        9.1.5 Market Breakup by Distribution Channel
        9.1.6 Key Players
        9.1.7 Market Forecast (​2024-2032​)
    9.2    South East
        9.2.1 Market Drivers
        9.2.2 Historical and Current Market Trends (​2018-2023​)
        9.2.3 Market Breakup by Product Type
        9.2.4 Market Breakup by Therapeutic Application
        9.2.5 Market Breakup by Distribution Channel
        9.2.6 Key Players
        9.2.7 Market Forecast (​2024-2032​)
    9.3    North West
        9.3.1 Market Drivers
        9.3.2 Historical and Current Market Trends (​2018-2023​)
        9.3.3 Market Breakup by Product Type
        9.3.4 Market Breakup by Therapeutic Application
        9.3.5 Market Breakup by Distribution Channel
        9.3.6 Key Players
        9.3.7 Market Forecast (​2024-2032​)
    9.4    East of England
        9.4.1 Market Drivers
        9.4.2 Historical and Current Market Trends (​2018-2023​)
        9.4.3 Market Breakup by Product Type
        9.4.4 Market Breakup by Therapeutic Application
        9.4.5 Market Breakup by Distribution Channel
        9.4.6 Key Players
        9.4.7 Market Forecast (​2024-2032​)
    9.5    South West
        9.5.1 Market Drivers
        9.5.2 Historical and Current Market Trends (​2018-2023​)
        9.5.3 Market Breakup by Product Type
        9.5.4 Market Breakup by Therapeutic Application
        9.5.5 Market Breakup by Distribution Channel
        9.5.6 Key Players
        9.5.7 Market Forecast (​2024-2032​)
    9.6    Scotland
        9.6.1 Market Drivers
        9.6.2 Historical and Current Market Trends (​2018-2023​)
        9.6.3 Market Breakup by Product Type
        9.6.4 Market Breakup by Therapeutic Application
        9.6.5 Market Breakup by Distribution Channel
        9.6.6 Key Players
        9.6.7 Market Forecast (​2024-2032​)
    9.7    West Midlands
        9.7.1 Market Drivers
        9.7.2 Historical and Current Market Trends (​2018-2023​)
        9.7.3 Market Breakup by Product Type
        9.7.4 Market Breakup by Therapeutic Application
        9.7.5 Market Breakup by Distribution Channel
        9.7.6 Key Players
        9.7.7 Market Forecast (​2024-2032​)
    9.8    Yorkshire and the Humber
        9.8.1 Market Drivers
        9.8.2 Historical and Current Market Trends (​2018-2023​)
        9.8.3 Market Breakup by Product Type
        9.8.4 Market Breakup by Therapeutic Application
        9.8.5 Market Breakup by Distribution Channel
        9.8.6 Key Players
        9.8.7 Market Forecast (​2024-2032​)
    9.9    East Midlands
        9.9.1 Market Drivers
        9.9.2 Historical and Current Market Trends (​2018-2023​)
        9.9.3 Market Breakup by Product Type
        9.9.4 Market Breakup by Therapeutic Application
        9.9.5 Market Breakup by Distribution Channel
        9.9.6 Key Players
        9.9.7 Market Forecast (​2024-2032​)
    9.10    Others
        9.10.1 Historical and Current Market Trends (​2018-2023​)
        9.10.2 Market Forecast (​2024-2032​)
    9.11    Attractive Investment Proposition by Region
10   Market Dynamics
    10.1     Market Driving Factors
    10.2     Market Restraining Factors
    10.3     Market Opportunities
11   Key Technological Trends & Development
12   Recent Industry News
13   Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14   Value Chain Analysis
15   UK Pharmaceuticals Export Market – Competitive Landscape 

    15.1    Overview
    15.2    Market Structure
    15.3    Market Share by Key Players
    15.4    Market Player Positioning
    15.5    Top Winning Strategies
    15.6    Competitive Dashboard
    15.7    Company Evaluation Quadrant
16   Competitive Landscape
    16.1    Company A
        16.1.1 Business Overview
        16.1.2 Products Offered
        16.1.3 Business Strategies
        16.1.4 SWOT Analysis
        16.1.5 Major News and Events
    16.2    Company B
        16.2.1 Business Overview
        16.2.2 Products Offered
        16.2.3 Business Strategies
        16.2.4 SWOT Analysis
        16.2.5 Major News and Events
    16.3    Company C
        16.3.1 Business Overview
        16.3.2 Products Offered
        16.3.3 Business Strategies
        16.3.4 SWOT Analysis
        16.3.5 Major News and Events
    16.4    Company D
        16.4.1 Business Overview
        16.4.2 Products Offered
        16.4.3 Business Strategies
        16.4.4 SWOT Analysis
        16.4.5 Major News and Events
    16.5    Company E
        16.5.1 Business Overview
        16.5.2 Products Offered
        16.5.3 Business Strategies
        16.5.4 SWOT Analysis
        16.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

17   Strategic Recommendations
18   Appendix

UK Pharmaceuticals Export Market Report by Product Type (Branded Pharmaceuticals, Generic Pharmaceuticals, OTC (Over-The-Counter) Drugs, Biopharmaceuticals, Active Pharmaceutical Ingredients (APIS), Vaccines), Therapeutic Application (Cardiovascular, Oncology, Central Nervous System (CNS), Infectious Diseases, Respiratory, Endocrinology, Dermatology, Gastroenterology, and Others), Distribution Channel (Direct Exports, Contract Manufacturing, Online Pharmacies, and Others), and Region  2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials